This course will dig into first principles and physiological understanding of glaucoma in order to best understand and apply current management strategies including medication, SLT, sustained release options, and surgical procedures. Advances in understanding of pathophysiology, genetics, and the goal of development of disease-modifying therapies are highlighted.
Speaker: Dr. Jessica Steen
Date: Monday, June 30th, 2025
Time: 5:30 PM - 6:30 PM Pacific Time
Location: Virtual
Moderator: Dr. Carolyn Majcher
Cost: Free!
COPE ID: 98056-GL
Category: Glaucoma
This event is undergoing COPE approval for 1 hour of CE credit.
Allergan is now AbbVie—Your Vision. Our Mission.
At AbbVie, we set our sights on a future where vision lasts a lifetime. With a legacy of more than 75 years in eye care, we are focused on preserving and protecting vision for patients around the world. We treat conditions from the front to the back of the eye, including glaucoma, ocular surface disease, and retinal diseases.